RE:RE:HOW MANY PATIENTS REQUIREDPILONG. I didnt say any of those things you implied I said. I pointed out merely that the number of patients for approval depends upon how successful the clinical trial results are. We won't really know how many are needed until phase 2 is complete. How many patients will be needed for phase 3 will be discussed with the FDA. That is the process. If phase 2 is marginal, it will require more patients, and better definition of type of patient and number of subjects. if it is shows really good efficacy, then the number of patients is less.